Plain-English translation of NCT07291973 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new device called the Endowave FlexAblate™ Microwave Ablation System, which uses microwave energy to destroy small lung tumors. The device is delivered through a thin tube (bronchoscope) passed down your airway, allowing doctors to treat the tumor without open surgery. Researchers want to confirm that this treatment is safe and effective for patients whose lung cancers cannot be removed surgically or who prefer not to have surgery.
Many patients with early-stage lung cancer or small tumors cannot have surgery due to poor lung function, other health conditions, or personal preference. This trial exists to evaluate whether this new microwave ablation device offers a safe and effective alternative option for these patients.
You likely qualify if…
You likely don't qualify if…
If you participate, you will undergo a bronchoscopic microwave ablation procedure, where doctors pass a thin tube with the ablation device through your airway to reach and treat your lung tumor. You will be followed for at least 30 days after the procedure with visits to check on your recovery and confirm that the treatment worked. During this time, you cannot receive other lung treatments on the same side to allow doctors to properly evaluate the results.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
France
United Kingdom